Advances in Experimental Medicine and Biology presents multidisciplinary and dynamic findings in the broad fields of experimental medicine and biology. The wide variety in topics it presents offers readers multiple perspectives on a variety of disciplines including neuroscience, microbiology, immunology, biochemistry, biomedical engineering and cancer research.
Advances in Experimental Medicine and Biology has been publishing exceptional works in the field for over 30 years and is indexed in Medline, Scopus, EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences.
The series also provides scientists with up to date information on emerging topics and techniques.
2017 Impact Factor: 1.760
Innovations in Cancer Research and Regenerative Medicine (ICRRM)
ICRRM is subseries of Advances in Experimental Medicine and Biology.
Innovations in Cancer Research and Regenerative Medicine brings together preeminent scientists working in the fields of cancer biology, cancer treatment, cancer diagnosis, cancer prevention, and regenerative medicine to share information on their current work and to help shape future therapies. Topics covered include tissue engineering, drug discovery, and nanotechnology, particularly as they relate to the fields of cancer research and regenerative medicine. Volumes also focus on therapy resistance, exosomes and microvesicles, signaling pathways of cancer and stem cells, and autophagy of cancer and stem cells. Bi-annually, Innovations in Cancer Research and Regenerative Medicine features proceedings volumes based on the conference of the same name, featuring well-established scientists in the field as well as outstanding up-and-comers.
If you would like to submit a manuscript to this series, please submit at here: http://submission.icrrm.com/jr-online_article_submission/